Legal
Refine Search
Biotechnology
India’s Sun Pharma has been blocked in its efforts to launch its JAK inhibitor Leqselvi (deuruxolitinib) in the USA. 6 November 2024
article
The European Union's antitrust enforcer hit Israeli drugmaker Teva Pharmaceutical Industries (NYSE: TEVA) with a 463 million-euro ($502 million) fine Thursday for launching a smear campaign against a rival multiple sclerosis drug and misusing the patent system to thwart the competitor's attempt to entering the market. 31 October 2024
Biotechnology
UK pharma major GSK has sued USA-based Moderna this week, accusing the latter of violating patents protecting GSK’s COVID-19 vaccine. 16 October 2024
Generics
Two US units of Israel’s Teva Pharmaceutical Industries have agreed to pay $450 million to resolve two matters that allege Teva violated the Anti-Kickback Statute (AKS) and the False Claims Act (FCA), the US Department of Justice (DoJ) announced yesterday. 11 October 2024
Pharmaceutical
GSK has reached a settlement with 10 plaintiff firms, resolving 93% of the Zantac (ranitidine) product liability cases it faced in state courts across the USA. 10 October 2024
Pharmaceutical
Cardiopulmonary diseases specialist Liquidia Corporation closed Monday’s trading 11% higher following a favorable court ruling. 8 October 2024
Generics
Novo Nordisk has reached a settlement with Mylan Pharmaceuticals, now part of Viatris, putting an end to a US patent lawsuit over blockbuster diabetes treatment Ozempic (semaglutide). 8 October 2024
Pharmaceutical
Texas Attorney General Ken Paxton has filed a lawsuit against major pharmaceutical companies, including Eli Lilly (NYSE: LLY), alleging a conspiracy to artificially inflate the prices of insulin by up to 1,000%. 7 October 2024
Biotechnology
Bristol Myers Squibb has scored a major legal victory as a judge in New York dismissed a $6.4 billion lawsuit related to its acquisition of cancer company Celgene. 5 October 2024
Pharmaceutical
The US Department of Health and Human Services (HHS) has released final guidance for the second cycle of Medicare drug price negotiations. 3 October 2024
Pharmaceutical
Texas-based Cassava Sciences was trading 13% lower in Friday’s pre-market trading. 27 September 2024
Pharmaceutical
The Pharmaceutical Research and Manufacturers of America (PhRMA) is continuing its legal challenge against the US government’s drug pricing reforms. 24 September 2024
Pharmaceutical
On Friday, the USA’s Federal Trade Commission (FTC) brought action against the three largest prescription drug benefit managers (PBMs) - Caremark Rx, Express Scripts (ESI), and OptumRx 23 September 2024
Pharmaceutical
In a lawsuit filed in federal court in Missouri, USA, Health insurer Cigna (NYSE: CI) and its pharmacy benefit manager (PBM) Express Scripts demanded that the Federal Trade Commission (FTC) retract its July 2024 report. 18 September 2024
Generics
Several pharma companies that had moved the Delhi High Court against the government’s recent notification banning 156 fixed-dose combination (FDC) drugs have got a breather. 10 September 2024
Generics
Glenmark Pharmaceuticals has agreed to pay $25 million, based on its ability to pay, to resolve its alleged liability under the False Claims Act for conspiring to fix the price of a generic drug, the US Department of Justice announced. 5 September 2024
Generics
German pharma major Bayer has filed a lawsuit against the Russian drugmaker Promomed to protect the patent rights for Xarelto (rivaroxaban), its treatment for stroke prevention which is the best-selling drug in the Russian market at present, The Pharma Letter’s local correspondent reports. 2 September 2024
Biosimilars
Regeneron Pharmaceuticals has filed a lawsuit against Sandoz, alleging that its biosimilar to Eylea (aflibercept) infringes certain patents. 29 August 2024
Pharmaceutical
Ireland-headquartered Avadel Pharmaceuticals has updated on litigation with USA-based Jazz Pharmaceuticals. 29 August 2024
Pharmaceutical
Liquidia Corporation announced Thursday that it has filed litigation in the US District Court of the District of Columbia (Case No. 1:24-cv-02428) that challenges the recent decision by the US Food and Drug Administration (FDA) to grant three-year new clinical investigation (NCI) exclusivity to Tyvaso (treprostinil) DPI.9.6. 23 August 2024
Pharmaceutical
The US Federal Trade Commission has said that its proposed $25 billion acquisition of St Jude Medical would likely be anticompetitive without certain divestments. 28 December 2016
Pharmaceutical
The Russian General Prosecutor's Office will check information about the bribes that were allegedly paid by Teva Russia to a certain Russian top official for the assistance in the promotion its products during state tenders for public procurement of drugs in Russia. 27 December 2016
Generics
Israel-based Teva Pharmaceutical Industries and its wholly-owned Russian subsidiary have agreed to resolve criminal charges and to pay a criminal penalty in connection with schemes involving the bribery of government officials in Russia, Ukraine and Mexico in violation of the Foreign Corrupt Practices Act (FCPA). 23 December 2016
Pharmaceutical
Denmark-based allergy specialist ALK-Abelló is to pay up to 238 million Danish kroner ($20 million) to acquire the activities and assets of Allergy Laboratories and Crystal Laboratory in a deal aimed at strengthening its US supply chain. 22 December 2016
Biotechnology
Gilead Sciences plans to appeal against a federal jury’s decision to hand the company a record fine in a US patent infringement case. 16 December 2016
Pharmaceutical
Ireland-incorporated drugmaker Allergan has announced that a $38 million settlement fee has been agreed to bring to an end a US federal investigation over the sales and marketing practices of its Forest subsidiary companies. 16 December 2016
Pharmaceutical
The US government has obtained more than $4.7 billion in settlements and judgments from civil cases involving fraud and false claims against the government in fiscal year 2016 ending September 30, with more than half coming from the health care industry. 15 December 2016
Generics
The US Department of Justice (DoJ) has announced two former senior generic pharmaceutical executives have been charged over price-fixing of generic medicines. 15 December 2016
Pharmaceutical
The UK regulator has ruled on breaches of the Association of British Pharmaceutical Industry code of conduct by five separate pharma companies. 13 December 2016
Generics
US specialty pharma Vanda Pharmaceuticals has come to an agreement with Canadian generics firm Apotex in a patent dispute over the schizophrenia drug Fanapt (iloperidone). 8 December 2016
Generics
Leading Indian drugmaker Sun Pharmaceutical Industries was trading 4.5% lower than it was at Tuesday’s close at a current 675.35 rupees after news that the US Food and Drug Administration (FDA) had raised further concerns about its Halol manufacturing plant in Gujarat. 8 December 2016
Pharmaceutical
US drugmaker Abbott has filed a complaint to terminate its proposed acquisition of Alere based on the substantial loss in Alere's value following the merger agreement. 8 December 2016
Pharmaceutical
The Belgian Competition Authority (BCA) has confirmed that it is inspecting several companies involved in the wholesale distribution of pharmaceutical and para-pharmaceuticals products to pharmacies. 25 November 2016
Biosimilars
Dynavax common stock plunged last Monday after receiving a complete response letter from the FDA regarding its approval application for Heplisav-B hepatitis vaccine. 20 November 2016
Generics
Valeant has issued a statement after learning that a criminal complaint was filed in relation to Philidor, a specialty pharmacy which is accused of pushing the products of the Canadian drugmaker. 18 November 2016
Biotechnology
The UK’s Court of Appeal has ruled that National Health Service (NHS) in England has the power to fund Pre-Exposure Prophylaxis (PrEP) for HIV. 10 November 2016
Pharmaceutical
A US federal agency has filed an amicus brief with the US Court of Appeals for the First Circuit urging the court to reverse the district court’s dismissal of the complaint relating to the anticoagulant Lovenox (enoxaparin). 9 November 2016
Biosimilars
Shares of USA-based Coherus BioSciences plunged as much as 17% after it was revealed that it had lost a patent battle which means that, for the time being at least, it cannot challenge a blockbuster biological drug with its biosimilar. 8 November 2016
Biosimilars
Biocad, one of Russia’s largest drugmakers, has won a legal action against pharma giant Roche in the Sri Lanka Court, which was initiated at the request of the Swiss company to ban sales of Biocad’s anti-cancer drugs in Sri Lanka as well as the cancellation of their registration. 7 November 2016
Pharmaceutical
It is starting to get ugly in the markets with the Nasdaq and S&P 500 posting their eight straight losing trading session Thursday. The US Department of Justice - which has some interesting choices of what it is and what it is not targeting this election year - deals the latest blow to the biopharma sector, wrote Bret Jensen on the Seeking Alpha blog. 6 November 2016
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze